Literature DB >> 29956295

The Role of Chromosome Deletions in Human Cancers.

Mei Chen1, Yi Yang1, Yu Liu1, Chong Chen2.   

Abstract

Chromosome deletions are a hallmark of human cancers. These chromosome abnormalities have been observed for over than a century and frequently associated with poor prognosis. However, their functions and potential underlying mechanisms remain elusive until recently. Recent technique breakthroughs, including cancer genomics, high throughput library screening and genome editing, opened a new era in the mechanistic studying of chromosome deletions in human cancer. In this chapter, we will focus on the latest studies on the functions of chromosome deletions in human cancers, especially hematopoietic malignancies and try to persuade the readers that these chromosome alterations could play significant roles in the genesis and drug responses of human cancers.

Entities:  

Keywords:  Chromosome deletion; Genome editing; Haploinsufficient tumor suppressor; Human cancer; Knudson’s two-hit hypothesis

Mesh:

Year:  2018        PMID: 29956295     DOI: 10.1007/978-981-13-0593-1_9

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  3 in total

Review 1.  Interstitial Deletions Generating Fusion Genes.

Authors:  Ioannis Panagopoulos; Sverre Heim
Journal:  Cancer Genomics Proteomics       Date:  2021 May-Jun       Impact factor: 4.069

2.  WT-PE: Prime editing with nuclease wild-type Cas9 enables versatile large-scale genome editing.

Authors:  Rui Tao; Yanhong Wang; Yun Hu; Yaoge Jiao; Lifang Zhou; Lurong Jiang; Li Li; Xingyu He; Min Li; Yamei Yu; Qiang Chen; Shaohua Yao
Journal:  Signal Transduct Target Ther       Date:  2022-04-20

3.  Chromosome 17p13 deletion is associated with an aggressive tumor phenotype in clear cell renal cell carcinoma.

Authors:  Till Eichenauer; Navid Shadanpour; Martina Kluth; Cosima Göbel; Sören Weidemann; Christoph Fraune; Franziska Büscheck; Claudia Hube-Magg; Christina Möller-Koop; Roland Dahlem; Margit Fisch; Michael Rink; Silke Riechardt; Eike Burandt; Christian Bernreuther; Sarah Minner; Ronald Simon; Guido Sauter; Waldemar Wilczak; Till Clauditz
Journal:  World J Surg Oncol       Date:  2020-06-13       Impact factor: 2.754

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.